Short-term efficacy of biologics targeting the IL-17/IL-23 axis in scalp, nail, and palmoplantar psoriasis: a network meta-analysis of randomized controlled trials.

Taltz (ixekizumab) - Eli Lilly

Bimzelx (bimekizumab-bkzx) - UCB

Tremfya (guselkumab) - J&J

Cosentyx (secukinumab) - Novartis

Stelara (ustekinumab) - J&J

Siliq (brodalumab) - Bausch Health

http://www.ncbi.nlm.nih.gov/pubmed/42558790

Guangzhong Zhang; Haomin Zhang; Lingling Li; Shouxu Zhang; TszLeong Lam; Xiaoxuan Chen; Yue Du

Aug 7, 2026